Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11884727 | Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis | Michal Eisenbach-Schwartz, Kuti Baruch | 2024-01-30 |
| 11884728 | Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis | Michal Eisenbach-Schwartz, Kuti Baruch | 2024-01-30 |
| 11643464 | Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder | Michal Eisenbach-Schwartz, Kuti Baruch | 2023-05-09 |
| 11492405 | Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2022-11-08 |
| 10981989 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2021-04-20 |
| 10961309 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2021-03-30 |
| 10618963 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2020-04-14 |
| 10519237 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2019-12-31 |
| 10214585 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2019-02-26 |
| 10144778 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-12-04 |
| 9982048 | Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-05-29 |
| 9982049 | Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-05-29 |
| 9982050 | Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-05-29 |
| 9982051 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-05-29 |
| 9982047 | Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-05-29 |
| 9856318 | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS | Michal Eisenbach-Schwartz, Kuti Baruch | 2018-01-02 |
| 9534052 | Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2017-01-03 |
| 9512225 | Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2016-12-06 |
| 9512227 | Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2016-12-06 |
| 9394365 | Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease | Michal Eisenbach-Schwartz, Kuti Baruch | 2016-07-19 |